ISRCTN63697536已完成未知
Safety and efficacy of fixed dose combination of Indapamide SR / Amlodipine in single-pill versus free dual therapy at the same dose over 12-week of treatment, with conditional titration based on the blood pressure control, in patients with mild to moderate uncontrolled essential hypertension: an international, multicentre, randomised, open-label study
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 150 人开始时间: 2014年4月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Men or women of any ethnic origin, 18 years or older
- •2. Mild to moderate essential combined systolic and diastolic hypertension or isolated systolic hypertension
排除标准
- •1. Pregnancy, breastfeeding or possibility of becoming pregnant during the study
- •2. Orthostatic hypotension
- •3. Hypertension known to be resistant to diuretics and calcium channel inhibitors (given separately or in combination)
- •4. Secondary hypertension
- •5. Complicated hypertension
- •6. Diabetes mellitus type I and type II under treatment
- •7. Any history or known severe disease likely to interfere with the conduct of the study
研究者
相似试验
进行中（未招募）
不适用
Safety and efficacy of fixed dose combination of Indapamide SR 1.5 mg / Amlodipine versus Valsartan / Amlodipine over 12-week of treatment in patients with uncontrolled essential hypertension after 1 month of treatment by Amlodipine 5 mg.ncontrolled essential hypertensionMedDRA version: 17.0Level: PTClassification code 10015488Term: Essential hypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2012-001690-84-PLInstitut de Recherches Internationales Servier448
进行中（未招募）
不适用
Safety and efficacy of fixed dose combination of Indapamide SR 1.5 mg / Amlodipine versus Valsartan / Amlodipine over 12-week of treatment in patients with uncontrolled essential hypertension after 1 month of treatment by Amlodipine 5 mg.ncontrolled essential hypertensionMedDRA version: 16.1Level: PTClassification code 10015488Term: Essential hypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2012-001690-84-HUInstitut de Recherches Internationales Servier448
进行中（未招募）
1 期
Safety and efficacy of fixed dose combination of Indapamide SR 1.5 mg / Amlodipine versus Valsartan / Amlodipine over 12-week of treatment in patients with uncontrolled essential hypertension after 1 month of treatment by Amlodipine 5 mg.EUCTR2012-001690-84-GBInstitut de Recherches Internationales Servier473
进行中（未招募）
不适用
Safety and efficacy of fixed dose combination of Indapamide SR 1.5 mg / Amlodipine versus Valsartan / Amlodipine over 12-week of treatment in patients with uncontrolled essential hypertension after 1 month of treatment by Amlodipine 5 mg.EUCTR2012-001690-84-LVInstitut de Recherches Internationales Servier448
进行中（未招募）
不适用
Safety and efficacy of fixed dose combination of Indapamide SR 1.5 mg / Amlodipine versus Valsartan / Amlodipine over 12-week of treatment in patients with uncontrolled essential hypertension after 1 month of treatment by Amlodipine 5 mg.ncontrolled essential hypertensionMedDRA version: 18.0Level: PTClassification code 10015488Term: Essential hypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2012-001690-84-LTInstitut de Recherches Internationales Servier448